Abstracts tagged "Neurologic involvement and vasculitis"

Abstract Number: 1806 • 2018 ACR/ARHP Annual Meeting
Spinal Cord Involvement in Behcet’s Disease- Experience of a Vasculitis Centre at Silk Road
Ertugrul Cagri Bolek, Alper Sari, Levent Kilic, Ali Akdogan, Meryem Asli Tuncer and Omer Karadag, Hacettepe University Vasculitis Center (HUVAC), Ankara, Turkey
Background/Purpose: Spinal cord involvement may occur in the course Behcet's Disease (BD). It may present with distinct manifestations such as sphincter and/or sexual dysfunction. We…
Abstract Number: 1807 • 2018 ACR/ARHP Annual Meeting
Clinical Features and Disease Course of Neurologic Involvement in Behcet’s Disease
Ertugrul Cagri Bolek, Alper Sari, Berkan Armagan, Abdulsamet Erden, Levent Kilic, Umut Kalyoncu, Meryem Asli Tuncer, Sedat Kiraz and Omer Karadag, Hacettepe University Vasculitis Center (HUVAC), Ankara, Turkey
Background/Purpose: Neurological involvement (NBD) is a rare complication of BD. Although NBD is not common in the course of BD, it is related with significant…
Abstract Number: 889 • 2015 ACR/ARHP Annual Meeting
Central Nervous System Involvement of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Retrospective Analysis of 26 Cases and Review of the Literature
Raphael André¹, Chahéra Khouatra², Jean-Luc Saraux³, Francois Maurier⁴, Gilles Blaison⁵, Boris Bienvenu⁶, Pascal Cathebras⁷, Nathalie Costedoat-Chalumeau⁸, Robin Dhote⁹, Aurélie Foucher¹⁰, Helder Gil¹¹, Joelle Lapouarie¹², David Launay¹³, Edouard Pertuiset¹⁴, Valentine Loustau¹⁵, Thierry Zenone¹⁶, Claire Le Jeunne¹⁷, Luc Mouthon¹⁸, Loïc Guillevin¹⁹ and Benjamin Terrier²⁰, ¹Cochin Hospital, Paris, France, ²CHU Lyon, Lyon, France, ³CH Eaubonne, Eaubonne, France, ⁴HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, ⁵Internal medicine, CHR, Colmar, France, ⁶Internal Medicine, Hospital Caen, Caen, France, ⁷Internal Medicine, University Hospital St Etienne, St Etienne, France, ⁸Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, ⁹Internal Medicine, Hospital Avicenne, Bobigny, France, ¹⁰CHU, Saint Pierre de la Réunion, France, ¹¹CHU, Besancon, France, ¹²CHU, Pau, France, ¹³Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, Lille, France, ¹⁴CH René Dubos, Pontoise, France, ¹⁵Hôpital Henri Mondor, Créteil, France, ¹⁶CH de Valence, Valence, France, ¹⁷Department of Internal Medicine, Hotel-Dieu Hospital, AP-HP, Paris, Paris, France, ¹⁸Department of Internal Medicine, Department of Internal Medicine, Cochin Hospital, Referent Center for Necrotizing Vasculitis and Systemic Sclerosis, Paris-Descartes University, AP-HP, Paris, France, ¹⁹Internal Medicine, Hopital Cochin, Paris, France, ²⁰Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France
Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by asthma, blood and tissue eosinophilia, vasculitis-related peripheral neuropathy, glomerulonephritis or skin symptoms. Although peripheral nervous system…
Abstract Number: 1550 • 2012 ACR/ARHP Annual Meeting
Long-Term Outcomes of Patients with Reversible Cerebral Vasoconstriction Syndromes (RCVS)
Seby John¹, Leonard H. Calabrese², Stewart Tepper³, Mark Stillman³, Ken Uchino¹ and Rula Hajj-Ali³, ¹Neurology, Cleveland Clinic Foundation, Cleveland, OH, ²Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH, ³Cleveland Clinic Foundation, Cleveland, OH
Background/Purpose: RCVS is a syndrome characterized by acute onset of severe headaches, with or without neurologic deficit with evidence of reversible cerebral vasoconstriction. Natural history…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].